Acciones del sector sanitario
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3249 |  IMRX Immuneering Corporation - Class A Common Stock | 4.96 USD | -0.60% | -6.94% | +19.52% | -12.06% | 320.90 M USD | ||
| 3253 |  SMTI Sanara MedTech Inc. - Common Stock | 34.76 USD | -0.34% | +1.05% | +2.84% | +3.95% | 319.38 M USD | ||
| 3265 |  TLSI TriSalus Life Sciences, Inc. - Common Stock | 5.12 USD | +3.43% | -0.19% | +13.53% | -2.10% | 315.26 M USD | ||
| 3269 |  EBS Emergent BioSolutions Inc. Common Stock | 6.12 USD | +0.49% | +13.33% | -16.85% | -42.91% | 313.79 M USD | ||
| 3272 |  RCEL Avita Medical, Inc. - Common Stock | 10.12 USD | +0.20% | -3.34% | +124.89% | +133.18% | 312.98 M USD | ||
| 3286 |  IRD Opus Genetics, Inc. - Common Stock | 3.71 USD | +2.49% | -13.11% | -0.27% | -0.27% | 308.66 M USD | ||
| 3295 |  RXST RxSight, Inc. - Common Stock | 7.31 USD | -0.27% | +17.34% | +19.84% | -19.58% | 304.05 M USD | ||
| 3307 |  TMCI Treace Medical Concepts, Inc. - Common Stock | 4.62 USD | -1.70% | -3.14% | +6.94% | -36.45% | 300.46 M USD | ||
| 3312 |  EMBC Embecta Corp. - Common Stock | 5.26 USD | +2.33% | +6.48% | +41.78% | -63.70% | 298.03 M USD | ||
| 3314 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 4.94 USD | -1.98% | -8.52% | +22.28% | +82.96% | 296.92 M USD | ||
| 3315 |  CV CapsoVision, Inc. - Common Stock | 5.93 USD | +1.54% | +1.89% | -11.62% | +62.91% | 296.78 M USD | ||
| 3317 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.02 USD | +1.01% | 0.00% | -1.82% | -9.90% | 296.14 M USD | ||
| 3321 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.87 USD | -0.51% | +0.26% | +6.61% | -39.53% | 295.27 M USD | ||
| 3324 |  PYXS Pyxis Oncology, Inc. - Common Stock | 3.53 USD | +8.95% | +15.74% | +30.74% | +175.78% | 294.43 M USD | ||
| 3334 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.77 USD | +1.77% | -1.41% | +12.95% | -2.30% | 291.03 M USD | ||
| 3336 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.42 USD | +1.26% | -3.20% | -0.41% | +132.69% | 289.97 M USD | ||
| 3344 |  MYGN Myriad Genetics, Inc. - Common Stock | 2.98 USD | -7.45% | -3.56% | +4.20% | -63.97% | 285.04 M USD | ||
| 3354 |  ANIK Anika Therapeutics Inc. - Common Stock | 21.06 USD | +0.91% | -2.00% | +7.50% | +107.69% | 281.85 M USD | ||
| 3357 |  SION Sionna Therapeutics, Inc. - Common Stock | 6.21 USD | +2.99% | +0.32% | -86.75% | -84.21% | 280.77 M USD | ||
| 3367 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.19 USD | -0.97% | -13.47% | +16.48% | +0.33% | 278.05 M USD |
Noticias Acciones del sector sanitario
Goldman Sachs actualiza sus listas de convicción a ambos lados del Atlántico
El regulador británico suspende el fármaco de Amgen Tavneos para nuevos pacientes
¿Por qué sube hoy la acción de Moderna?
BTIG eleva el precio objetivo de Kazia Therapeutics tras datos del ensayo
El director de RRHH de Ardelyx, James Brady, vende acciones por 58.378 dólares
¿Por qué se dispara hoy la acción de Arcturus Therapeutics?
¿Por qué las acciones de MiniMed se disparan hoy?
Gainers Acciones del sector sanitario
 FEED ENvue Medical, Inc. - Common Stock | 4.19 | +1097.14% |
 KAPA Kairos Pharma, Ltd. Common Stock | 1.61 | +570.83% |
 NIVF NewGenIvf Group Limited - Class A Ordinary Shares | 1.33 | +195.56% |
 BEATW Heartbeam, Inc. - Warrant | 0.0147 | +63.33% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 6.59 | +44.52% |
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0552 | +26.90% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0126 | +24.75% |
 MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.91 | +18.18% |
Losers Acciones del sector sanitario
 ALMS Alumis Inc. - Common Stock | 8.97 | -58.87% |
 PMI Picard Medical, Inc. Common Stock | 5.28 | -36.23% |
 HKPD Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares | 0.22 | -33.33% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -31.82% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0003 | -25.00% |
 TNONW Tenon Medical, Inc. - Warrant | 0.0074 | -24.49% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.2102 | -21.60% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.13 | -18.75% |